Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terazosin and Tolterodine for Urinary Stent Symptoms
NCT01530243Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jan 2012
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of terazosin, tolterodine in ureteral stent syndrome (SRS), sponsored by Urmia University of Medical Sciences. Started Jan 2012; status: completed.
02
Drugs
terazosintolterodine
03
Conditions
ureteral stent syndrome (SRS)
Beyond the preview
Go deeper on NCT01530243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01530243.